A detailed history of Israel Englander (Millennium Management LLC) transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 32,172 shares of SPRO stock, worth $36,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,172
Previous 98,518 67.34%
Holding current value
$36,032
Previous $128,000 66.41%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.19 - $1.5 $78,951 - $99,519
-66,346 Reduced 67.34%
32,172 $43,000
Q2 2024

Aug 14, 2024

SELL
$1.27 - $1.8 $62,679 - $88,837
-49,354 Reduced 33.38%
98,518 $128,000
Q1 2024

May 15, 2024

SELL
$1.35 - $1.79 $1,329 - $1,763
-985 Reduced 0.66%
147,872 $254,000
Q4 2023

Feb 14, 2024

SELL
$1.0 - $1.47 $224,993 - $330,739
-224,993 Reduced 60.18%
148,857 $218,000
Q2 2023

Aug 14, 2023

SELL
$1.42 - $1.95 $171,381 - $235,347
-120,691 Reduced 24.4%
373,850 $542,000
Q1 2023

May 15, 2023

SELL
$1.35 - $2.0 $515,506 - $763,714
-381,857 Reduced 43.57%
494,541 $717,000
Q4 2022

Feb 14, 2023

BUY
$1.55 - $2.12 $291,403 - $398,564
188,002 Added 27.31%
876,398 $1.52 Million
Q3 2022

Nov 14, 2022

BUY
$0.68 - $2.2 $254,152 - $822,256
373,753 Added 118.79%
688,396 $1.38 Million
Q2 2022

Aug 15, 2022

BUY
$0.74 - $7.44 $187,502 - $1.89 Million
253,382 Added 413.61%
314,643 $233,000
Q1 2022

May 16, 2022

BUY
$7.87 - $15.15 $482,124 - $928,104
61,261 New
61,261 $533,000
Q2 2021

Aug 16, 2021

SELL
$12.22 - $15.79 $154,399 - $199,506
-12,635 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$13.23 - $21.48 $600,999 - $975,771
-45,427 Reduced 78.24%
12,635 $186,000
Q4 2020

Feb 16, 2021

SELL
$11.65 - $22.07 $844,764 - $1.6 Million
-72,512 Reduced 55.53%
58,062 $1.13 Million
Q3 2020

Nov 16, 2020

BUY
$8.96 - $14.12 $847,445 - $1.34 Million
94,581 Added 262.78%
130,574 $1.46 Million
Q2 2020

Aug 14, 2020

BUY
$7.27 - $14.18 $159,489 - $311,080
21,938 Added 156.09%
35,993 $487,000
Q1 2020

May 14, 2020

BUY
$5.27 - $10.41 $7,235 - $14,292
1,373 Added 10.83%
14,055 $114,000
Q4 2019

Feb 14, 2020

BUY
$9.46 - $12.16 $119,971 - $154,213
12,682 New
12,682 $122,000
Q2 2018

Aug 14, 2018

SELL
$10.41 - $17.85 $118,830 - $203,757
-11,415 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$9.96 - $14.61 $113,693 - $166,773
11,415 New
11,415 $163,000

Others Institutions Holding SPRO

About Spero Therapeutics, Inc.


  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $39.3M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.